Bennicas & Associates, Inc. Gilead Sciences, Inc. Transaction History

Bennicas & Associates, Inc.

$157 Million
Q4 2022

A detailed history of Bennicas & Associates, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bennicas & Associates, Inc. holds 17,166 shares of GILD stock, worth $1.17 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

17,166

Previous 17,166 -0.0%

Holding current value

$1.17 Million

Previous $1.47 Million 0.07%

% of portfolio

0.94%

Previous 0.85%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$62.32 - $89.47 $6,232 - $8,947	-100 Reduced 0.58%	17,166 $1.47 Million
Q3 2022 Oct 13, 2022	SELL	$59.54 - $68.01 $52,097 - $59,508	-875 Reduced 4.82%	17,266 $1.07 Million
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $5,772 - $6,501	-100 Reduced 0.55%	18,141 $1.12 Million
Q1 2022 Apr 15, 2022	SELL	$57.92 - $72.58 $7,240 - $9,072	-125 Reduced 0.68%	18,241 $1.08 Million
Q4 2021 Jan 14, 2022	SELL	$64.88 - $73.64 $34,062 - $38,661	-525 Reduced 2.78%	18,366 $1.33 Million

Q2 2021 Jul 09, 2021	BUY	$63.47 - $69.35 $38,082 - $41,610	600 Added 3.28%	18,891 $1.3 Million
Q1 2021 Apr 15, 2021	SELL	$60.0 - $68.46 $9,000 - $10,268	-150 Reduced 0.81%	18,291 $1.18 Million
Q4 2020 Jan 15, 2021	SELL	$56.65 - $64.55 $79,310 - $90,370	-1,400 Reduced 7.06%	18,441 $1.07 Million
Q3 2020 Oct 15, 2020	BUY	$62.1 - $78.08 $4,098 - $5,153	66 Added 0.33%	19,841 $1.25 Million
Q2 2020 Jul 14, 2020	SELL	$72.34 - $84.0 $1,808 - $2,100	-25 Reduced 0.13%	19,775 $1.52 Million
Q1 2020 Apr 15, 2020	SELL	$62.63 - $80.22 $50,104 - $64,176	-800 Reduced 3.88%	19,800 $1.48 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $49,296 - $54,224	-800 Reduced 3.74%	20,600 $1.34 Million
Q3 2019 Oct 07, 2019	SELL	$62.51 - $69.0 $9,376 - $10,350	-150 Reduced 0.7%	21,400 $1.36 Million
Q2 2019 Jul 12, 2019	SELL	$61.87 - $69.38 $12,374 - $13,876	-200 Reduced 0.92%	21,550 $1.46 Million
Q1 2018 Apr 20, 2018	SELL	$72.84 - $88.8 $40,062 - $48,840	-550 Reduced 2.47%	21,750 $1.64 Million
Q4 2017 Jan 24, 2018	SELL	$71.15 - $83.52 $21,345 - $25,056	-300 Reduced 1.33%	22,300 $1.6 Million
Q3 2017 Oct 25, 2017	BUY	$72.11 - $85.47 $1.63 Million - $1.93 Million	22,600	22,600 $1.83 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bennicas & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bennicas & Associates, Inc. with notifications on news.

Account

Bennicas & Associates, Inc. Gilead Sciences, Inc. Transaction History